← Browse by Condition
Medical Condition
human papillomavirus
Total Trials
3
Recruiting Now
3
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for human papillomavirus sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Top Sponsors
1 trial
1 trial
1 trial
NCT06434337
Recruiting
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
Enrollment
600 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05365048
Recruiting
Provider Recommendation and HPV Vaccination
Enrollment
301,201 pts
Location
United States
Sponsor
Kaiser Permanente
NCT04901351
Recruiting
Multi-site HPV Screening by High-throughput Sequencing in Patients With Chronic HPV-HR Infection Followed by Gynecology
Enrollment
30 pts
Location
France
Sponsor
University Hospital, Toulouse
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology